encukalner experimental small molecule anticonvulsant selective potassium channel opener investigated treatment refractory focal onset major depressive works selectively opening voltagegated potassium channels via positive allosteric modulation opening voltagegated potassium channels critical regulators neuronal excitability leads increase flow potassium ions neurons resulting neurons becoming hyperpolarized hyperpolarized resting state reduces ability neuron fire thereby decreasing likelihood mechanism action shares similarities medication retigabine withdrawn market due link skin pigmentation retinitis different structure appear cause effect development chromophoric phenaziniumtype dimers resulted side effect